Integer Holdings Corporation (ITGR) Next Earnings Date & Expected ±1.8% Move

$126.59 +0.06% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $126.36

Integer Holdings Corporation (ITGR) carries a Roarable Rating of C+ (Hold) with 67/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.

ROARABLE C+ • HOLD / WATCH Cap $4.30B
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on ITGR Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is ITGR stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-03, Integer Holdings Corporation (NYSE: ITGR) is rated C+ (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 67/100 at a spot price of $126.59 (+0.06% 1D, market cap $4.30B). Pillar breakdown: Fundamental Cash Engine 14/20, Institutional 13F & Options Flow 16/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 11/20. Across 1016 tracked Health Care issuers, ITGR ranks #106 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does ITGR compare to LIVN and AXGN in the Health Care sector?
▼

Within the Health Care sector (Biotechnology: Electromedical & Electrotherapeutic Apparatus), ITGR carries a Roarable C+ (67/100 RQD), trailing P/E of 41.8x, gross margin of 27.0%, and ROIC of 6.0%. By comparison, LIVN (LivaNova PLC) holds a C+ grade (66/100 RQD, P/E N/A, ROIC 17.3%, cap $4.35B) and AXGN (Axogen Inc.) posts a D+ grade (53/100 RQD, P/E N/A, ROIC -2.6%, cap $2.95B). Among the 5-stock peer group, TMDX leads on earnings multiple (12.2x) while TMDX leads on capital efficiency (18.1% ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for ITGR?
▼

Per ITGR's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001114483), Integer Holdings Corporation generated $1.85B in revenue (+8.0% YoY), $102.8M in net income, and $105.1M in free cash flow against $3.41B in total assets and $1.19B in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side.. Primary risk factors monitored: Priced at 42x earnings—high expectations leave less room for a lukewarm quarter.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $126.36 (-0.18%)🧬 Cannibal Buyback (-0.96% YoY Shares)⚙️ Cash Engine: 14/20 (B-) • 5.7% FCF Margin
Verify 90D Bucket Audit →
📊 Historical Track Record: Scores of 67/100 (C+) historically posted market-perform odds over rolling 90-day windows (+1.6% avg 90D alpha vs SPY • 56.4% hit rate — wait for RQD ≥ 70 breakout).
Audit Bucket Track Record →
RQD QUANT TACHOMETERHOLD / WATCH • C+
025507510067
2-of-3 JEV AI Jury Bullish
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw C+ · Rk C
Cash (14)Whales (16)SEC (13)Macro (13)CEO (11)
Each axis scored 0–20
12M PRICE TARGET CONE+4.1% Base Target
$155 Bull$132 Base$103 Bear
📬 FREE ITGR RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for ITGR)Realized 20D OHLCV Swing Band: ±1.8%
Deterministic 5-Pillar Attribution (67/100 Composite)
🔍 WHY ITGR SCORES 67/100 (C+) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Whale & Options Positioning+16/20 pts (24% of score)

20D Institutional Volume Accumulation (±1.8% realized swing band)

▲ #2 Bullish Driver: Cash Engine Quality+14/20 pts (21% of score)

SEC XBRL FY 2025 (10-K): 5.7% FCF Margin ($105.1M FCF) & 27% Gross Margin

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution11/20 pts (-9 pt drag)

Cannibal Buyback (-0.96% YoY Shares) & executive Form 4 sales trim 9 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
75
Grade B+$126.61+0.1% Next Q
Q2 (-2Q)
72
Grade B$126.70-0.1% Next Q
Q3 (-1Q)
70
Grade B$126.55+0% Next Q
Current
67
Grade C+$126.59+1.6% Hist 90D α
Trajectory: B+ (75) → C+ (67)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the ITGR Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 67/100 (C+) score, ITGR faces multiple-compression risk if 41.8x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Priced at 42x earnings—high expectations leave less room for a lukewarm quarter.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Cannibal Buyback (-0.96% YoY Shares) — any gross margin slip below 24.5% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($126.28) or 200D SMA ($101.43) invalidates the momentum regime and cuts Target Base ($131.72) toward Bear Floor ($102.74).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $ITGR• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “ITGR Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
NEXT EST. WINDOW: Dec 30, 2026 (~57 DAYS)

Historical OHLCV Volatility ±1.8% Swing Band

±$2.28 Expected Swing
$124.31 (-1.8%)Spot $126.59$128.87 (+1.8%)
MODEL EARNINGS SETUP GAUGE

ITGR Quantitative Pre-Earnings Setup: 67/100

Trailing EPS: $3.02 • YoY Revenue Growth: 8%

Model Bullish Setup (67/100)Model Risk Weight (33/100)
Derived deterministically from RQD cash-flow quality, SEC accrual safety, and institutional flow (not a community poll).
LOG YOUR PERSONAL PRE-EARNINGS STANCE (SAVED LOCALLY IN BROWSER):

Recent SEC Reported Revenue, Net Profit & Diluted EPS Cadence

PeriodFiledRevenueNet ProfitFree Cash FlowGross Margin
FY 20252025-12-31$1.85B$102.8M$105.1M27%
FY 20242024-12-31$1.72B$119.9M$99.8M26.7%
FY 20232023-12-31$1.56B$90.7M$110.2M27%
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher + Options & Swing Structure Desk

Whale Flow & Momentum Playbook: Evaluating ITGR & AI Leaders Without Chasing Tops

  • ✓Institutional whale strikes & implied earnings move audit on ITGR
  • ✓How disciplined traders manage risk using pre-published trigger & invalidation levels
  • ✓Includes nightly RQD rating-change & forensic signal email alerts on tracked leaders
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
ITGR // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +50.79%⚡ TESTING RESISTANCE
2026-11-03O $126.5H $126.6L $126.5C $126.6VOL 571.7K
RES: $126.8SUP: $126.6SMA50: $126.3SMA200: $101.4
$129.9$117.2$104.6$91.97$79.34RES $126.8SUP $126.6$126.62026-05-042026-06-182026-08-052026-09-212026-11-03
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

ITGR Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)
31.6%/yr Implied 5Y Growth

vs. +8.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on ITGR today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for ITGR. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for ITGR today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (ITGR)

Health Care Rank #106 of 1016 ⚔️ LIVN vs ITGR Full Matrix →

1. Head-to-Head Health Care Peer Comparison (ITGR vs. LIVN, AXGN, TMDX, CNMD)

Industry: Biotechnology: Electromedical & Electrotherapeutic Apparatus (26 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Integer Holdings Corporation (ITGR) ranks #106 by composite RQD confidence (67/100, grade C+) and #172 by equity capitalization ($4.30B). Within this direct 5-issuer industry benchmark cohort, TMDX leads on earnings valuation at 12.2x trailing P/E, while TMDX leads on capital efficiency and profitability with 18.1% ROIC and 59.9% gross margin. ITGR currently leads its immediate peer cohort in composite quantitative strength at 67/100 (C+).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
ITGR ACTIVE
Integer Holdings Corporation
C+ 67/100 41.8x 27.0% 6.0% +0.06% $4.30B Benchmark Subject
LIVN
LivaNova PLC
C+ 66/100 — 67.7% 17.3% -2.81% $4.35B /livn-vs-itgr →
AXGN
Axogen Inc.
D+ 53/100 — 74.3% -2.6% -0.52% $2.95B /axgn-vs-itgr →
TMDX
TransMedics Group Inc.
C- 61/100 12.2x 59.9% 18.1% -1.68% $2.29B /tmdx-vs-itgr →
CNMD
CONMED Corporation
C 62/100 28.9x 54.6% 7.8% -3.13% $1.32B /cnmd-vs-itgr →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001114483

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Integer Holdings Corporation (ITGR) reported GAAP revenue of $1.85B (+8.0% vs. FY2024 revenue of $1.72B , and +19.2% cumulative change since FY2023) , GAAP net income of $102.8M, operating cash flow of $196.1M, and free cash flow of $105.1M (+5.3% YoY). On the balance sheet, ITGR closed FY2025 with $3.41B in total assets against $1.19B in total debt (Altman Z-Score: 2.91, Piotroski F-Score: 7/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $1.85B $102.8M $196.1M $105.1M $3.41B $1.19B
FY2024 (FY) 2024-12-31 $1.72B $119.9M $205.2M $99.8M $3.08B $980.2M
FY2023 (FY) 2023-12-31 $1.56B $90.7M $180.2M $110.2M $2.37B $553.5M

3. ITGR Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is ITGR stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-03, Integer Holdings Corporation (NYSE: ITGR) is rated C+ (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 67/100 at a spot price of $126.59 (+0.06% 1D, market cap $4.30B). Pillar breakdown: Fundamental Cash Engine 14/20, Institutional 13F & Options Flow 16/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 11/20. Across 1016 tracked Health Care issuers, ITGR ranks #106 in composite RQD confidence.

How does ITGR compare to LIVN and AXGN in the Health Care sector?

Within the Health Care sector (Biotechnology: Electromedical & Electrotherapeutic Apparatus), ITGR carries a Roarable C+ (67/100 RQD), trailing P/E of 41.8x, gross margin of 27.0%, and ROIC of 6.0%. By comparison, LIVN (LivaNova PLC) holds a C+ grade (66/100 RQD, P/E N/A, ROIC 17.3%, cap $4.35B) and AXGN (Axogen Inc.) posts a D+ grade (53/100 RQD, P/E N/A, ROIC -2.6%, cap $2.95B). Among the 5-stock peer group, TMDX leads on earnings multiple (12.2x) while TMDX leads on capital efficiency (18.1% ROIC).

What are the biggest fundamental strengths and SEC risk factors for ITGR?

Per ITGR's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001114483), Integer Holdings Corporation generated $1.85B in revenue (+8.0% YoY), $102.8M in net income, and $105.1M in free cash flow against $3.41B in total assets and $1.19B in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side.. Primary risk factors monitored: Priced at 42x earnings—high expectations leave less room for a lukewarm quarter.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is ITGR trading relative to its 50-day, 200-day, and 52-week technical levels?

ITGR last traded at $126.59 (+0.06% on volume of 571,724 shares), positioning the stock +0.25% above its 50-day simple moving average ($126.28) and +24.81% above its 200-day simple moving average ($101.43). Across its 52-week range of $66.00 to $126.83, ITGR sits at the 99.6% percentile with a 14-day RSI of 61.4 (BULLISH MOMENTUM) and an implied next-earnings move of ±1.8% ($124.31 to $128.87).

ITGR Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

When is ITGR's next earnings date?

Based on SEC filing cadence, Integer Holdings Corporation (ITGR)'s next quarterly reporting window is estimated around Dec 30, 2026.

How much is ITGR stock expected to move on earnings?

Volatility modeling currently projects a ±1.8% event move for ITGR, spanning a range between $124.31 and $128.87.

ROARABLE RATING BRIEF • RQD 67/100 (C+) ✓ STAGE-C NUMBER FIREWALL VERIFIED

ITGR — Integer Holdings Corporation: What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5
As of: 2026-11-02T15:21:54Z

Roarable Rating Brief: What This Means to a Prospective Investor

Per the Roarable RQD rating, ITGR scores 67 out of 100, a letter grade of C+, with the verdict "Roarable Hold — Upper Neutral / Watch for Breakout." The five pillars are: Fundamental Cash Engine at 14 of 20 (ROIC 6%; FCF yield 2.44%), Whale 13F Flow at 16 of 20 (institutional accumulation and options positioning), Insider Conviction at 11 of 20 (SEC Form 4 and Congressional PTR cluster flow), Macro Regime Fit at 13 of 20 (Beta 1.02; sector sensitivity), and Forensic Balance Sheet at 13 of 20 (Altman Z 2.91; Piotroski F 7/9; Debt/Equity 0.68).

For a prospective investor, the rating's strongest pillar is institutional positioning, which the RQD places at 16 of 20, while insider conviction is the weakest at 11 of 20. The cash-engine pillar is moderate: the RQD attributes 14 of 20 to it, consistent with the 6% ROIC and 2.44% FCF yield shown in the market data. The forensic pillar (13 of 20) reflects a Piotroski score of 7 of 9 and an Altman Z-Score of 2.91, alongside a Debt/Equity ratio of 0.68. Upside drivers implied by the scoring are institutional accumulation and balance sheet strength; valuation tradeoffs are visible in the elevated P/E (TTM) of 41.8 and forward P/E of 38.9 relative to a 2.44% FCF yield. The verdict's "Watch for Breakout" language signals the rating system views the stock as near neutral with potential for a directional move, not as a conclusive buy or sell. This is an analytical summary, not personalized financial advice.

Snapshot

PriceMarket CapP/E (TTM)Forward P/EEV/EBITDAEPS (TTM)Dividend YieldBeta52-Wk RangeROIC %
126.52$4.3B41.838.918.33.020%1.02$63.75 - $126.836%

Financial Trend

PeriodRevenueOperating IncomeNet IncomeEPSFCFCashDebt
FY 2025$1853.6M$221.3M$102.8MN/A$105.1M$17.2M$1185.2M
FY 2024$1716.6M$208.2M$119.9MN/A$99.8M$46.5M$980.2M
FY 2023$1555.7M$163.3M$90.7MN/A$110.2MN/A$553.5M

Per the market data, gross margin is 27%, operating margin 11.9%, and net margin 5.5%, with ROIC at 6%. Per the RQD forensic pillar, the Altman Z-Score is 2.91 and the Piotroski F-Score is 7 of 9. The balance sheet shows debt rising from $553.5M (FY 2023) to $1185.2M (FY 2025) while cash fell from $46.5M (FY 2024) to $17.2M (FY 2025). Debt/Equity is 0.68 per the RQD forensic inputs.

Open Questions

  • What drove the increase in debt from $553.5M to $1185.2M over FY 2023 to FY 2025, and how is it scheduled to be serviced?
  • Why are EPS figures reported as N/A in the financial periods when EPS (TTM) of 3.02 is provided in market data?
  • What is the cash position for FY 2023, which is listed as N/A?
  • What specific catalysts or news could drive the "breakout" the verdict references?

ITGR Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Integer Holdings Corporation (ITGR) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to ITGR Debate Forum (3) ↓
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

ITGR Bull vs. Bear Conversation Board — What's Your Call at $126.59?

🐂 50% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON ITGR 🐻 50% BEARISH CONVICTION
1. Pick Your Side on ITGR:
💡 Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
RO RoarDesk_Moderator Roarable Research Desk ⚖️ DEBATE HOST 🎯 Target: $136.64 (+8.0%)
📌 Pinned Debate

🔥 Official Bull vs. Bear Debate: Is ITGR (C+ • RQD 67/100) a Buy at $126.52?

Welcome to the ITGR (Integer Holdings Corporation) Roar Pit. Current RQD Composite is 67/100 (Roarable Hold — Upper Neutral / Watch for Breakout) in Biotechnology: Electromedical & Electrotherapeutic Apparatus. Bulls point to operating leverage and sector positioning, while bears focus on valuation multiple compression (41.8x trailing P/E). Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.

VA ValDiscipline Forensic Accounting Watch 🐻 BEARISH 🎯 Target: $99.95 (-21.0%)
Spot @ $126.52

Pump the brakes on ITGR — check the valuation vs. margin headwinds

Everyone in here is repeating the bull case on ITGR, but look at what you are paying: 41.8x trailing P/E with 27.0% gross margins. Unless Integer Holdings Corporation expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.

AL AlphaFlow_Cap Verified K Arena Trader 🐂 BULLISH 🎯 Target: $156.88 (+24.0%)
Spot @ $126.52

ITGR cash flow & RQD setup is being underpriced by the Street here

Looking at the 5-pillar RQD breakdown on ITGR, the market is fixating on short-term headline noise in Biotechnology: Electromedical & Electrotherapeutic Apparatus and ignoring the balance sheet and cash flow trajectory. At $126.52 (52-wk range $63.75 - $126.83), any beat on forward guidance forces shorts and underweight funds to chase.

LIVE TAPE SPY $752.10 -1.80% QQQ $681.09 -3.60% DIA $519.34 -1.08% IWM $279.14 -1.68% NVDA $204.64 -4.22% AAPL $344.63 -1.23% MSFT $521.91 -1.55% TSLA $399.81 -0.86% PLTR $184.11 -6.27% SOFI $16.76 -4.83% IBIT $43.35 -5.42% GLD $361.65 -3.59%